A cyclometalated iridium complex with tumor hypoxia sensing and photoactivity and its application
A technology of iridium complexes and ring metals, which is applied in the direction of indium organic compounds, platinum group organic compounds, and medical preparations containing active ingredients, etc., can solve the problems of affecting the therapeutic effect and the decrease of photodynamic efficiency, and achieve good stability, Good mitochondrial targeting performance and enhanced photodynamic therapy activity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0035] The synthesis of embodiment 1 complex Mito-IrL3
[0036]
[0037] Take the synthesized iridium complex chlorine bridge dimer Ir 2 (iqbt) 4 Cl 2 (154mg, 0.1mmol), L3 (157mg, 0.2mmol) and a mixed solvent of dichloromethane and methanol (12mL, 2:1, volume ratio) were placed in a reaction vessel, and heated to reflux for 6h under an argon atmosphere. After the reaction, the reaction mixture was cooled to room temperature, and ten times the equivalent of ammonium hexafluorophosphate was added. The suspension was stirred for 15 min and filtered to remove insoluble inorganic salts. The solvent was evaporated under reduced pressure, and column chromatography gave dark red Mito-IrL3 solid (56%). 1 H NMR (400MHz, CD 3 CN-d 3)δ9.21(dd, J=8.3, 1.4Hz, 1H), 9.07(dd, J=13.3, 8.8Hz, 2H), 8.30(dd, J=5.1, 1.4Hz, 1H), 8.15(dd, J =5.1, 1.2Hz, 1H), 7.97–7.80(m, 12H), 7.75–7.65(m, 18H), 7.55(d, J=8.8Hz, 2H), 7.45–7.34(m, 3H), 7.24– 7.13(m, 4H), 6.84-6.81(m, 2H), 6.70(q, J=7.6, 7.1...
Embodiment 2
[0038] The synthesis of embodiment 2 complex IrL4
[0039]
[0040] Take the synthesized iridium complex chlorine bridge dimer Ir 2 (iqbt) 4 Cl 2 (154mg, 0.1mmol), L4 (89mg, 0.2mmol) and a mixed solvent of dichloromethane and methanol (12mL, 2:1, volume ratio) were placed in a reaction vessel, and heated to reflux for 6h under an argon atmosphere. After the reaction, the reaction mixture was cooled to room temperature, and ten times the equivalent of ammonium hexafluorophosphate was added. The suspension was stirred for 15 min and filtered to remove insoluble inorganic salts. The solvent was evaporated under reduced pressure, and column chromatography gave dark red IrL4 solid (61%). 1 H NMR (400MHz, CD 3 CN-d 3 )δ9.13(d, J=8.3Hz, 1H), 9.04(dd, J=14.7, 8.5Hz, 2H), 8.25(d, J=4.4Hz, 1H), 8.12(d, J=4.4Hz, 1H), 7.96–7.72(m, 9H), 7.71–7.51(m, 6H), 7.48(d, J=8.7Hz, 2H), 7.42–7.32(m, 3H), 7.18-7.11(m, 4H) , 6.78(d, J=8.7Hz, 2H), 6.69-6.64(m, 2H), 6.19(t, J=7.1Hz, 2H), 3.91(...
Embodiment 3
[0043] Example 3 Study on the Response of Complexes Mito-IrL3 and IrL4 to Oxygen Concentration
[0044] The phosphorescence response of 10μM complexes Mito-IrL3 and IrL4 to oxygen concentration was studied in toluene.
[0045] Experimental results such as figure 1 as shown, figure 1 a is the phosphorescence emission spectrum of the complex Mito-IrL3 at different oxygen concentrations, figure 1 c is the attenuation curve of the intensity of the phosphorescent emission peak at 685 nm of Mito-IrL3 toluene solution (10 μM) with the increase of oxygen concentration. figure 1 b is the phosphorescence emission spectrum of the complex IrL4 at different oxygen concentrations, figure 1 d is the attenuation curve of the intensity of the phosphorescent emission peak at 685 nm of IrL4 toluene solution (10 μM) with the increase of oxygen concentration.
[0046] pass figure 1 a It can be seen that the phosphorescence intensity response experiment of the complex Mito-IrL3 to oxygen conce...
PUM
Property | Measurement | Unit |
---|---|---|
wavelength | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com